SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-062270
Filing Date
2024-05-16
Accepted
2024-05-16 07:30:14
Documents
13
Period of Report
2024-05-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2414630d1_8k.htm   iXBRL 8-K 23535
  Complete submission text file 0001104659-24-062270.txt   196582

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA syn-20240513.xsd EX-101.SCH 3042
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20240513_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20240513_pre.xml EX-101.PRE 22378
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2414630d1_8k_htm.xml XML 3692
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 24953560
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)